Literature DB >> 1310615

Higher-order complex formation between the 72-kilodalton type IV collagenase and tissue inhibitor of metalloproteinases-2.

D E Kleiner1, E J Unsworth, H C Krutzsch, W G Stetler-Stevenson.   

Abstract

The collagenases are a class of matrix degradative enzymes whose actions are important in physiological and pathological processes. The human 72-kDa type IV collagenase (matrix metalloproteinase-2) and its proteinase inhibitor, tissue inhibitor of metalloproteinases-2 (TIMP-2), are produced as a proenzyme-inhibitor complex by numerous cell lines. We analyzed the quaternary structure of and enzyme-inhibitor interactions in the native enzyme-inhibitor complex by studying the pattern of complexes demonstrated by molecular weight determination in nondenaturing polyacrylamide gels and evaluating the products formed by reaction of the native complexes with cross-linking agents. Electrophoresis in native polyacrylamide gels demonstrates that approximately 79% of the latent enzyme is present in a 1:1 bimolecular complex with the inhibitor TIMP-2, with 21% present as a complete tetrameric complex of two molecules of collagenase combined with two molecules of TIMP-2. The enzyme complex activated with organomercurials displays a shift to a higher proportion of the bimolecular complex with only 5% present as higher molecular weight complexes. Cross-linking of the latent and active forms of the complex with bis(sulfosuccinimidyl) suberate (BS3) and bis(sulfosuccinimidyl) tartarate demonstrates both the 1:1 and 2:2 complexes as well as an intermediate form that appears to be a complex composed of two molecules of collagenase and one of TIMP-2. The distribution of cross-linked products is unchanged with the addition of excess TIMP-2 to the reaction mix, implying that the binding sites for TIMP-2 to the initial enzyme-inhibitor complex are all occupied when the stoichiometry is 1 to 1.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1310615     DOI: 10.1021/bi00121a013

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

1.  ProMMP-2: TIMP-1 complexes identified in plasma of healthy individuals.

Authors:  Stanley Zucker; Cathleen E Schmidt; Antoine Dufour; Robert C Kaplan; Hyun I Park; Weiping Jiang
Journal:  Connect Tissue Res       Date:  2009       Impact factor: 3.417

Review 2.  Matrix metalloproteinases. Novel targets for directed cancer therapy.

Authors:  A E Yu; R E Hewitt; E W Connor; W G Stetler-Stevenson
Journal:  Drugs Aging       Date:  1997-09       Impact factor: 3.923

3.  Macromolecule-Network Electrostatics Controlling Delivery of the Biotherapeutic Cell Modulator TIMP-2.

Authors:  Yuji Yamada; Ananda Chowdhury; Joel P Schneider; William G Stetler-Stevenson
Journal:  Biomacromolecules       Date:  2018-03-19       Impact factor: 6.988

4.  Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.

Authors:  T Yoneda; A Sasaki; C Dunstan; P J Williams; F Bauss; Y A De Clerck; G R Mundy
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

5.  Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface.

Authors:  K Lehti; J Lohi; H Valtanen; J Keski-Oja
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

6.  Expression and secretion of active mouse TIMP-1 using a baculovirus expression vector.

Authors:  E T Cocuzzi; S E Walther; D T Denhardt
Journal:  Inflammation       Date:  1994-02       Impact factor: 4.092

7.  Expression of human recombinant 72 kDa gelatinase and tissue inhibitor of metalloproteinase-2 (TIMP-2): characterization of complex and free enzyme.

Authors:  R Fridman; R E Bird; M Hoyhtya; M Oelkuct; D Komarek; C M Liang; M L Berman; L A Liotta; W G Stetler-Stevenson; T R Fuerst
Journal:  Biochem J       Date:  1993-01-15       Impact factor: 3.857

8.  Bone sialoprotein binding to matrix metalloproteinase-2 alters enzyme inhibition kinetics.

Authors:  Alka Jain; Larry W Fisher; Neal S Fedarko
Journal:  Biochemistry       Date:  2008-05-08       Impact factor: 3.162

9.  Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate.

Authors:  Y Itoh; S Binner; H Nagase
Journal:  Biochem J       Date:  1995-06-01       Impact factor: 3.857

10.  Interaction between tissue inhibitor of metalloproteinases-2 and progelatinase A: immunoreactivity analyses.

Authors:  N Fujimoto; R V Ward; T Shinya; K Iwata; K Yamashita; T Hayakawa
Journal:  Biochem J       Date:  1996-02-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.